Injectable Product Stability
Injectable Product Stability is a pharmaceutical quality attribute that refers to the capacity of a sterile injectable formulation to remain chemically, physically, and microbiologically intact and within specified limits under defined storage and usage conditions over time.
17
Publications
494
Citations
57
Authors
24
Institutions
Publications per year
2017–2026
3
Parents
17
Physical and biochemical stability of Optison, an injectable ultrasound contrast agent.
Sheila Podell, Cindy Burrascano, Marc Gaal et al. · PubMed · 1999 · 82 citations
Stability studies: five years later.
Lawrence A. Trissel, Karl P. Flora · PubMed · 1988 · 80 citations
1–5 of 17
57
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 57
24
Ansys (United States)
Canonsburg, United States
2 h-index
12 publications
930 citations
Abbott (United States)
Chicago, United States
1 h-index
2 publications
40 citations
Centre Hospitalier Régional et Universitaire de Nancy
Nancy, France
1 h-index
1 publications
10 citations

Banaras Hindu University
Varanasi, India
1 h-index
4 publications
64 citations
National Cancer Institute
Bethesda, United States
1 h-index
2 publications
160 citations

University of Oslo
Oslo, Norway
1 h-index
2 publications
34 citations

Chiang Mai University
Chiang Mai, Thailand
1 h-index
4 publications
52 citations
University Medical Center of the Johannes Gutenberg University Mainz
Mainz, Germany
1 h-index
1 publications
10 citations
1–8 of 24
Repository · 4 publications · 208 citations
4
h-index
AJHP · 2 publications · 35 citations
2
h-index
1 publications · 73 citations
1
h-index
1 publications · 15 citations
1
h-index
1 publications · 15 citations
1
h-index
1–5